| |
Innovation and expertise
in inhalation technologies
Our experience in inhalation products started with
corticosteroid APIs, which we have been manufacturing for the past forty
years. With a view to helping customers solve complex problems we have
invested in building know-how and expertise in particle design and formulation
development for highly sophisticated inhalation APIs.
At Hovione we can tailor-make particle size ranges and incorporate desired
morphology characteristics into your API. We are also able to start with
a Hovione-produced API and develop a dry powder formulation to meet your
demands.
The key technical capabilities that support our inhalation
offering include:
| • |
Particle size reduction |
| • |
Particle Design technologies |
| • |
Cascade impaction (Andersen and NGI) |
| • |
Stability studies of inhalation powders |
| • |
Inhalation powders formulation |
| • |
Excipient identification, sourcing and
characterization |
| • |
Microbiology controls |
To complement our inhalation formulation service
line, we have developed two innovative dry powder devices, the capsule-based
refillable FlowCaps® and the single-use disposable TwinCaps™,
both available for licensing.
In addition to inhalation formulation services and devices
we also offer:
| • |
Capsules for inhalation |
| • |
Capsules filling, for both clinical
and commercial purposes |
| • |
Dosed API for early phase clinical studies |
|
|
|
Satisfying your needs
About Hovione 
